Heart Failure

The approval of medications like statins and PCSK9 inhibitors to help lower cholesterol levels have proven helpful but a recent study looked at whether patients were getting not only the treatments they needed but whether they were getting the right dosage levels to help improve their health.

As new medications are introduced to the market there can be some hesitation by doctors to make the jump from more traditional treatment options. Moving beyond that has shown benefits for a patient's long term health.

It has been several years since Eliquis was approved as an oral anticoagulant but still more research is being done to show its benefits in helping patients with non-valvular atrial fibrillation.

To say that a patient has been diagnosed with myocardial infarction may not paint the full picture of the diagnosis. Recent research has shown there is a second type of the condition which not as much is known about across the spectrum.

What happens when a patient with type 2 diabetes uses both a potassium (K)-sparing agent and sodium-glucose co-transporter 2 (SGLT2) inhibitor at the same time?

Like many other areas of medicine cardiology is becoming a more specialized field. How to do that to provide better care for doctors is a common goal across medicine.

When treating a woman during pregnancy there are many factors that need to be considered, not the least of them being her cardiovascular health. At Montefiore Medical Center a team approach aims to help prevent fatal events during this delicate time in a patient's life.

Congenital heart disease may have the same name in adult and pediatric care but the two conditions can often require vastly different approaches in care. Despite that work in the field is being done to help patients of all age maintain a high quality of life.

A lot has been done to bolster the treatment of congenital heart disease and managing the risks of this patient population. Because of that these patients are able to live a longer and fuller life including pregnancy and childbirth like other people.

Even the most severe cases of congenital heart disease can be treated to a level where they can safely navigate high risk pregnancies.

There are many ways patients can better manage their cholesterol than they could just a few years ago. Whether they are successful in those efforts and the role of doctors and medications in that process remains to be seen.

Even as technology improves to help patients dealing with cardiovascular disease, those responsible for the procedures also must consider providing treatment while weighing the costs of that work.

For those how enter the field of genetic testing there are many challenges along the way, starting with finding the right training program through using that training in very difficult situations.

Hopes that losmapimod would benefit patients after a STEMI heart attack were not borne out by a study reported today at the American College of Cardiology's meeting in Chicago, IL.

Despite a considerable gap between the number of patients who require a transplant and the number of organs available those patients fortunate enough to receive the lifesaving organs are seeing greater success from the procedure.

There is no shortage of people in need of a kidney transplant but a considerable shortage in the number of organs available to these patients. Despite that health care professionals in nephrology are determined to provide their patients the highest quality of life possible in spite of these challenges.

As with all areas of health care money is an important consideration for hospitals and other medical research institutions. Finding the most effective way to spend money to get the best results can be a difficult balancing act across the board.

As technology improves and more is learned about treatment for various conditions new guidelines are constantly being developed in the medical field. Once the guidelines are updated it becomes even more important to get that information into the field to help the patients who can benefit from them.

In the changing landscape of hospital medicine one of the largest areas of focus has been on readmission rates, this is also true for patients who are discharged from one hospital and then readmitted into another location for further treatment.

From cardiologists to physical therapists to nurses there is a team approach needed to provide cardiac patients the care they need for treatment. Keeping that care going even after a cardiac event has passed has been a growing focus of the field in recent years.

Even in hospital settings patients can suffer fatal cardiac events if they are not properly monitored. This is especially true at night when staffing numbers drop and families are not with their loved ones until morning.

Congestive heart failure is a serious condition facing people around the world. Early trials of a gene therapy have showed promise to not only help these patients with the condition but also make their hearts healthier.

Several large groups combined data to look at results of a study on heart failure patients to see whether age and gender affected treatment options prescribed by patients.

Heart failure may be one of the most common conditions a cardiologist sees on a daily basis but there are also many misconceptions about its treatment and diagnosis. Whether on the football field or running an endurance race there are also other issues doctors are working to address across the scope of the cardiology field.